Evidence map›Paper›PMID 26794131›Full record

ArticleDisease models & mechanisms2016

Multimodal analysis of ocular inflammation using the endotoxin-induced uveitis mouse model.

Colin J Chu, Peter J Gardner, David A Copland, Sidath E Liyanage, Anai Gonzalez-Cordero, Sophia-Martha Kleine Holthaus, Ulrich F O Luhmann, Alexander J Smith, Robin R Ali, Andrew D Dick

Open access · goldAbstract read
In one paragraph

Article in Disease models & mechanisms, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Autophagy Regulates Müller Glial Cell Inflammatory Activation.Investigative ophthalmology & visual science · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Biomedical optics express · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Colin J ChuSchool of Clinical Sciences, University of Bristol, Bristol BS8 1TD, UK colin.chu@bristol.ac.uk a.dick@bristol.ac.uk.
Peter J GardnerUCL Institute of Ophthalmology, 11-43 Bath Street, London EC1V 9EL, UK.
David A CoplandSchool of Clinical Sciences, University of Bristol, Bristol BS8 1TD, UK.
Sidath E LiyanageUCL Institute of Ophthalmology, 11-43 Bath Street, London EC1V 9EL, UK.
Anai Gonzalez-CorderoUCL Institute of Ophthalmology, 11-43 Bath Street, London EC1V 9EL, UK.
Sophia-Martha Kleine HolthausUCL Institute of Ophthalmology, 11-43 Bath Street, London EC1V 9EL, UK.
Ulrich F O LuhmannUCL Institute of Ophthalmology, 11-43 Bath Street, London EC1V 9EL, UK Roche Pharmaceutical Research and Early Development, Ophthalmology Discovery & Biomarkers, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, Basel 4070, Switzerland.
Alexander J SmithUCL Institute of Ophthalmology, 11-43 Bath Street, London EC1V 9EL, UK.
Robin R AliUCL Institute of Ophthalmology, 11-43 Bath Street, London EC1V 9EL, UK NIHR Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital and UCL Institute of Ophthalmology, London EC1V 9EL, UK.
Andrew D DickSchool of Clinical Sciences, University of Bristol, Bristol BS8 1TD, UK UCL Institute of Ophthalmology, 11-43 Bath Street, London EC1V 9EL, UK NIHR Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital and UCL Institute of Ophthalmology, London EC1V 9EL, UK colin.chu@bristol.ac.uk a.dick@bristol.ac.uk.
University College London · GBUniversity of Bristol · GBRoche (Switzerland) · CH

Funding

Medical Research Council G1100383Medical Research Council MR/K003003/1Medical Research Council MR/L012758/1Medical Research Council MR/L022699/1
6 · The paper itself

Abstract

Endotoxin-induced uveitis (EIU) in rodents is a model of acute Toll-like receptor 4 (TLR4)-mediated organ inflammation, and has been used to model human anterior uveitis, examine leukocyte trafficking and test novel anti-inflammatory therapeutics. Wider adoption has been limited by the requirement for manual, non-specific, cell-count scoring of histological sections from each eye as a measure of disease severity. Here, we describe a comprehensive and efficient technique that uses ocular dissection and multimodal tissue analysis. This allows matched disease scoring by multicolour flow cytometric analysis of the inflammatory infiltrate, protein analysis on ocular supernatants and qPCR on remnant tissues of the same eye. Dynamic changes in cell populations could be identified and mapped to chemokine and cytokine changes over the course of the model. To validate the technique, dose-responsive suppression of leukocyte infiltration by recombinant interleukin-10 was demonstrated, as well as selective suppression of the monocyte (CD11b+Ly6C+) infiltrate, in mice deficient for eitherCcl2orCcr2 Optical coherence tomography (OCT) was used for the first time in this model to allowin vivoimaging of infiltrating vitreous cells, and correlated with CD11b+Ly6G+ counts to provide another unique measure of cell populations in the ocular tissue. Multimodal tissue analysis of EIU is proposed as a new standard to improve and broaden the application of this model.

Indexed as

AnimalsCell CountChemokine CCL2CytokinesDisease Models, AnimalEndotoxinsEyeFemaleFlow CytometryInflammationMice, Inbred C57BLNeutrophil InfiltrationNeutrophilsReceptors, CCR2Severity of Illness IndexTomography, Optical CoherenceCcr2 protein, mouseChemokine CCL2CytokinesEndotoxinsReceptors, CCR2EIUFlow cytometryOCT

Identifiers

PMID26794131
PMCPMC4852501
OpenAlexW2318211916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.